Cite
MLA Citation
D Gray Heppner et al.. “Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study.” Lancet infectious diseases, vol. 17, no. 8, n.d., pp. 854–866. http://access.bl.uk/ark:/81055/vdc_100049766263.0x00003c